Consensus recommendations for optimal trial design and reporting of core domains in urate-lowering therapy trials for gout: A Delphi study
Methodological detailsthree-round Delphi survey, two panels: patient research partners and other interest holders, consensus: ≥70% of both groups scoring 7-9 on a 1-9 scale
- Three-round Delphi survey
- Two panels: patient research partners and other interest holders
- Consensus: ≥70% of both groups scoring 7-9 on a 1-9 scale
Recommendations
As issued by the authors
Reporting: all 7 core domains had more than one item reach consensus
Serum urate reporting: proportion of patients achieving a pre-specified target serum urate, mean serum urate and mean change in serum urate
Measurement timing: baseline and final visit for all 7 core domains
Serum urate frequency: monthly in trials ≤6 months; 3-monthly in trials >6 to ≤12 months
Original publication
Consensus recommendations for optimal trial design and reporting of core domains in urate-lowering therapy trials for gout: A Delphi study. Semin Arthritis Rheum. Published 18 September 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →